期刊
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
卷 21, 期 4, 页码 773-782出版社
SPRINGER JAPAN KK
DOI: 10.1007/s10147-016-0952-6
关键词
Androgen receptor inhibitor; Enzalutamide; Metastatic castration-resistant prostate cancer
类别
资金
- Astellas Pharma, Inc.
- Medivation, Inc.
- Grants-in-Aid for Scientific Research [16K11019] Funding Source: KAKEN
分享论文
